Argenx

AVEO Oncology is a Boston-based biopharmaceutical company dedicated to improving the lives of cancer patients through innovative medical solutions. As a subsidiary of LG Chem, the company focuses on developing and delivering effective treatments that address the unique challenges faced by individuals battling cancer. Committed to scientific advancement, AVEO's portfolio includes several promising therapies, such as FOTIVDA, Ficlatuzumab, and AV-380. The company's mission is driven by a passion for enhancing the quality of life for those affected by cancer, underscoring their focus on patient-centered care. Generated from the website

Vertex Pharmaceuticals Incorporated is a global biotechnology company engaged in the discovery and development of breakthrough small molecule drugs for serious diseases. The company commercializes its products independently and in collaboration with major pharmaceutical companies. Vertex s product line includes drugs for viral diseases, inflammation, autoimmune diseases and cancer. Vertex is developing treatments for cancer, HIV and AIDS and pain through collaborations with some of the leading pharmaceutical companies. The company has collaborations with Cystic Fibrosis Foundation Therapeutics, GlaxoSmithKline, Kissei Pharmaceutical, Merck & Co., Mitsubishi Pharma Corporation and Novartis Pharma. Vertex co-promotes the HIV and AIDS protease inhibitor, Lexiva, with GlaxoSmithKline. Vertex Pharmaceuticals Incorporated is located in Cambridge, Mass.

Paratek Pharmaceuticals is a privately held biopharmaceutical company, which is engaged in the discovery and commercialization of new therapeutics that treat life-threatening infectious and other serious diseases. The company s mission at its founding was to overcome the major worldwide problem of bacterial resistance through the application of its proprietary technologies. Paratek was founded in 1996 by Dr. Stuart B. Levy, professor at Tufts University School of Medicine, and by Dr. Walter Gilbert, a Nobel Prize-winning professor emeritus at Harvard University. The company utilizes two scientific platforms to develop multiple products to combat, cure and prevent infectious and other serious diseases. Paratek Pharmaceuticals is headquartered in Boston.